University of Illinois wins FDA approval for saliva COVID-19 test
The University of Illinois System received Emergency Use Authorization from the U.S. Food and Drug Administration on Monday for its saliva-based COVID-19 test, as the statewide seven-day rolling positivity rate reached 2.4 percent.
The FDA approval allows for the covidSHIELD test to expand beyond the U of I System. The saliva-based COVID-19 test has been administered more than 1.5 million times at universities in Urbana-Champaign, Chicago and Springfield since it launched in 2020, according to a news release.
Gov. J.B. Pritzker says he will be dedicating $20 million in federal CARES Act funding to provide one million of the saliva-based tests to Illinoisâ 12 public universities and 48 community colleges.
The Globe and Mail CONTENT FROM GLOBE CONTENT STUDIO Published February 22, 2021
SUPPLIED
Clean technology is a trillion-dollar global industry, but can Canada compete?
“Canadians have long been great innovators,” says Kevin Nilsen, President and CEO of ECO Canada, which is based in Calgary.
He points to the two Canadians who patented a design for a light bulb, Henry Woodward and Matthew Evans. But two years later, American Thomas Edison bought the patent and has since been credited with the invention.
Story continues below advertisement
“We haven’t always been the best at supporting organizations to commercialize and to set up a strong, competitive business,” Mr. Nilsen says. “That’s why sometimes some of the great innovations are bought by other countries.”
MOSCOW, Feb. 24, 2021 /PRNewswire/ The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by